logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Endocrine & Metabolism drugs

    FiltersReset Filters
    65 results

    • admelog

      (insulin lispro)
      Sanofi-Aventis U.S. LLC
      Usage: ADMELOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

    • afrezza

      (INSULIN HUMAN)
      Mannkind Corporation
      Usage: AFREZZA® is a rapid-acting inhaled human insulin for improving glycemic control in adults with diabetes mellitus. It is not recommended for diabetic ketoacidosis and its safety in smokers has not been established.

    • androgel

      (Testosterone)
      ASCEND Therapeutics U.S., LLC
      Usage: AndroGel 1.62% is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions. Its safety and efficacy in age-related hypogonadism and in males under 18 have not been established.

    • atorvaliq

      (ATORVALIQ)
      CMP Pharma, Inc.
      Usage: ATORVALIQ is indicated to reduce the risk of cardiovascular events in adults with risk factors for coronary heart disease, type 2 diabetes, and clinically evident coronary heart disease. It also lowers LDL cholesterol in various conditions, including primary hyperlipidemia and familial hypercholesterolemia, as an adjunct to diet or other therapies.

    • aveed

      (testosterone undecanoate)
      ENDO USA, Inc.
      Usage: AVEED is indicated for testosterone replacement therapy in adult males with conditions related to testosterone deficiency, including primary and hypogonadotropic hypogonadism. It should only be used when benefits outweigh risks, with safety and efficacy not established for age-related hypogonadism or in males under 18.

    • basaglar

      (Insulin glargine)
      Eli Lilly and Company
      Usage: BASAGLAR® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus, and in adults with type 2 diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.

    • bijuva

      (estradiol and progesterone)
      Mayne Pharma LLC
      Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

    • brenzavvy

      (Bexagliflozin)
      TheracosBio, LLC
      Usage: BRENZAVVY is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes mellitus.

    • carbaglu

      (Carglumic Acid)
      Recordati Rare Diseases
      Usage: CARBAGLU is indicated for adult and pediatric patients as adjunctive therapy and maintenance treatment for acute and chronic hyperammonemia due to N-acetylglutamate Synthase (NAGS) deficiency, as well as adjunctive therapy for acute hyperammonemia caused by Propionic Acidemia or Methylmalonic Acidemia.

    • climara pro

      (Estradiol and Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.
      • ...